AI assistant
HAEMONETICS CORP — Director's Dealing 2012
Oct 30, 2012
31565_dirs_2012-10-30_e4c1cc1c-2c34-4cdd-9d99-8545a206eabb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2012-10-26
Reporting Person: FORISH JOSEPH J (VP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-10-26 | Common Stock | D | 180.0 | $78.51 | Disposed | 8622.0 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $51.07 | 2014-10-24 | Common Stock (11799.0) | 11799.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $52.94 | 2016-10-27 | Common Stock (14690.0) | 14690.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $54.55 | 2015-10-22 | Common Stock (11911.0) | 11911.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $54.99 | 2017-10-27 | Common Stock (15388.0) | 15388.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $61.34 | 2018-10-25 | Common Stock (15370.0) | 15370.0 | Direct |
| Non-Qualified Stock Option (right to buy) | $78.11 | 2019-10-24 | Common Stock (3576.0) | 3576.0 | Direct |
Footnotes
F1: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.
F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
F3: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
F4: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.